Addex Therapeutics Ltd. (ADXN) stock
ADXNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.50−0.33 (-8.62%)
Close on Nov 17, 2026Market cap $71.86KP/E –Yield –
Addex Therapeutics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Addex Therapeutics's total debt was CHF 0 at Dec 31, 2025. For fiscal 2025 it was CHF 0. The highest annual figure on record is CHF 0 in fiscal 2018.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | CHF 0 | – |
| FY2024 | Dec 31, 2024 | CHF 0 | – |
| FY2023 | Dec 31, 2023 | CHF 0 | – |
| FY2022 | Dec 31, 2022 | CHF 0 | – |
| FY2021 | Dec 31, 2021 | CHF 0 | – |
| FY2020 | Dec 31, 2020 | CHF 0 | – |
| FY2019 | Dec 31, 2019 | CHF 0 | – |
| FY2018 | Dec 31, 2018 | CHF 0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | CHF 0 | – |
| Q4 FY2024 | Dec 31, 2024 | CHF 0 | – |
| Q4 FY2023 | Dec 31, 2023 | CHF 0 | – |
| Q4 FY2022 | Dec 31, 2022 | CHF 0 | – |
| Q4 FY2021 | Dec 31, 2021 | CHF 0 | – |
| Q4 FY2020 | Dec 31, 2020 | CHF 0 | – |
| Q4 FY2019 | Dec 31, 2019 | CHF 0 | – |
| Q4 FY2018 | Dec 31, 2018 | CHF 0 | – |
See a number that looks wrong?